Business Potential for Agricultural Biotechnology - Asian Productivity ...
Business Potential for Agricultural Biotechnology - Asian Productivity ...
Business Potential for Agricultural Biotechnology - Asian Productivity ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Business</strong> <strong>Potential</strong> <strong>for</strong> <strong>Agricultural</strong> <strong>Biotechnology</strong> Products<br />
(Boyer and Shannon, 2003; Carey et al., 1982; Marshall and Tracey, 2003; Sprague and Dudley,<br />
1988). Conventional plant breeding is also being used to combine two or more separately developed<br />
biotechnology-derived traits. <strong>Biotechnology</strong>-derived combined-trait products were first<br />
introduced in 1997 and were grown on 6.8M ha globally in 2004 (James, 2004). Examples of<br />
crops that are being grown or developed through the combination of biotechnology-derived traits<br />
by conventional breeding include varieties of maize that combine the Roundup Ready, Yield-<br />
Gard ® Corn Borer, and YieldGard Rootworm traits and varieties of cotton that combine the<br />
Roundup Ready trait with either Bollgard ® or Bollgard II ® traits.<br />
Any new regulatory requirements <strong>for</strong> combined-trait crops should be carefully considered<br />
to determine whether they address risks that are any greater than those in crops developed by<br />
conventional methods. Australia, Canada, and the U.S. do not generally require submission of<br />
additional safety data on combined-trait products developed by conventional breeding if the<br />
single-trait products have completed the regulatory process and the two traits are unrelated. The<br />
U.S. EPA regulates products that contain two insect-control traits, requiring the identification of<br />
any synergistic effects and confirmation that the insect resistance management (IRM) plan <strong>for</strong><br />
the combined-trait product is appropriate. Canada and Australia require that developers notify<br />
them of their intent to commercialize combined-trait products. Canada also reserves the right to<br />
request data demonstrating that combined-trait products are substantially equivalent to the<br />
parents, although this has not been done to date <strong>for</strong> the currently commercial combined-trait<br />
products.<br />
Japanese regulatory authorities recently issued guidelines <strong>for</strong> combined-trait products,<br />
based on a classification system. Category 1 includes traits that do not alter a metabolic pathway<br />
of host plants, <strong>for</strong> example, agronomic traits such as insect protection or herbicide resistance.<br />
Category 2 includes traits that alter a metabolic pathway of host plants, resulting in the enhancement<br />
of nutritional content. Category 3 includes traits that introduce new metabolites that have<br />
previously not been present in the host plant. Based on this classification scheme, there is no<br />
need <strong>for</strong> a separate review <strong>for</strong> combined-trait products developed by conventional breeding of<br />
Category 1 traits, as long as the individual traits have been previously reviewed. A separate food<br />
safety review is required <strong>for</strong> combined-trait products comprised of Category 2 or Category 3<br />
traits. Whether the individual traits are related or interact metabolically will be key to determining<br />
if additional safety data are required <strong>for</strong> combined-trait products that contain Category 2<br />
or 3 traits.<br />
In Korea, a notification system is in place where the applicant files a justification <strong>for</strong><br />
exemption from further safety assessment of the combined-trait product, based on three criteria:<br />
no change in the stacked-trait progeny produced from conventional crossing of the single traits<br />
(other than the additional trait), no crossing between different species, and no change anticipated<br />
in the resulting human consumption levels, edible plant portions, or purpose of usage. If the<br />
product is not exempted, a separate safety assessment must take place, with data requirements to<br />
be specified.<br />
In the Philippines, developers submit a notification <strong>for</strong> evaluation of combined-trait<br />
products <strong>for</strong> which the individual traits have prior approval and where the combined-trait products<br />
are used directly <strong>for</strong> food, feed, or processing. A risk assessment is conducted on possible or<br />
expected interactions between genes or gene products, where the potential <strong>for</strong> genetic interaction<br />
to <strong>for</strong>m new allergen or toxins, affect protein compartmentalization, or change phenotypic characteristics<br />
and the impact on mode of action and protein levels <strong>for</strong> single- and combined-trait<br />
products are assessed.<br />
The Republic of China has a voluntary notification process <strong>for</strong> traits combined by conventional<br />
breeding and where the individual traits have received prior approval. In some other Asia–<br />
® YieldGard, Bollgard, and Bollgard II are registered trademarks of Monsanto Technology LLC.<br />
– 28 –